(精选)【医学课件课件】产前诊断教学课件.pptVIP

產前診斷 Prenatal Diagnosis;Prenatal Screening;Genetic History;Prior History;Family History;Ethnic Background;Thalassemia;Cystic Fibrosis; ; ;Maternal Serum Screening;Maternal Serum Screening;孕婦血清甲型胎兒蛋白昇高可能之原因;New Possibilities;Ultrasound;Ultrasound;Ultrasound – Soft Signs;Ultrasound – Soft Signs;Ultrasound;產前遺傳診斷技巧;產前診斷的一般準則;產前診斷的應用;Invasive Testing;Fetus (10-12 weeks);Invasive Testing;Invasive Testing;Invasive Testing;Fetal Cells in the Maternal Circulation;Preimplantation Genetic Diagnosis (PGD);PGD;遺傳病治療(Gene Therapy); 基因 基因產物 代謝作用 功能作用 構造作用 ;Genetic diagnosis;In Vitro Fertilization;In Vitro Fertilization;In Vitro Fertilization;Treatment of Genetic Diseases;Gene Transfer;Viral Replication;Adenovirus;Retroviruses;Adenoviruses;Problems Associated with Viral Gene Therapy;基因新科技;Human Genome Project;;Human Genome Project;What Is a Genome?;“Central Dogma” of Modern Genetics;Genomics: Derivative Studies;Genomics: Derivative Studies;Genomics and Derivative Studies;Promise of theHuman Genome Project;Genomic Medicine;Screening: Examples;Genetics in the News;Genetic Banking;Down Syndrome;Prenatal Diagnosis;Newborn Screening;Genetic Variation;Genetics in Medicine;Models;Medicine in Transformation;;Cardiomyopathy;;2010;2015;Clinicians will use family history and genetic testing to identify patients who need further evaluation and/or management;Disease StratificationTargeted Therapy;ALOX5 Polymorphism and Asthma;Targeted Therapy;Avoidance of Adverse Effects;Avoidance of Adverse Effects;Proc. Natl. Acad. Sci. (USA) 2000;97:106133-10618.;SCN5A polymorphism;CYP2D6;Drugs Metabolized by CYP2D6;Pharmacogenetic Testing;Therapeutics;Education of physicians and the general public Access to information Tools for screening, education Protection of individual rights and privacy Knowledge of outcomes Development of new prevention strategies and treatments